Skip Navigation

Vaccine Safety Bibliography - July 2013

1.   Behring's new method of inoculation against diphtheria. JAMA. 2013 Jun 26;309(24):2525.

2.   Committee opinion no. 566: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2013 Jun; 121(6):1411-4.

3.   Influenza activity - United States, 2012-13 season and composition of the 2013-14 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):473-9.

4.   Nationwide rubella epidemic in Japan, 2013. Wkly Epidemiol Rec. 2013 Jun 14;88(24):251-6.

5.   Outbreak news. Poliomyelitis, Somalia and Kenya. Wkly Epidemiol Rec. 2013 Jun  14;88(24):241-2.

6.   Paediatric rheumatology: HPV vaccine safe and effective in patients with JIA.  Nat Rev Rheumatol. 2013 Jun 18. [Epub ahead of print].

7.   Progress towards measles elimination in the Western Pacific Region, 2009-2012. Wkly Epidemiol Rec. 2013 Jun 7;88(23):233-40.

8.   Provider Recommendation Linked to HPV Vaccination Among Young U.S. Females. Perspect Sex Reprod Health. 2013 Jun; 45(2):112.

9.  Rotavirus vaccines WHO position paper: January 2013 - Recommendations. Vaccine. 2013 Jun 5. [Epub ahead of print].

10.  The "Stop Transmission of Polio (STOP)" programme of the Global Polio Eradication Initiative, 1999-2013. Wkly Epidemiol Rec. 2013 Jun 21; 88(25):257-60.

11.  Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine  Among Children Aged 6-18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR  Morb Mortal Wkly Rep. 2013 Jun 28;62(25):521-4.

12.  Ahmed R, Burton DR. Viral vaccines: past successes and future challenges. Curr Opin Virol. 2013 Jun 25. [Epub ahead of print].

13.  Al-Tawfiq JA, Abukhamsin A, Memish ZA. Epidemiology and impact of varicella vaccination: A longitudinal study 1994-2011. Travel Med Infect Dis. 2013 Jun 27. [Epub ahead of print].

14.  Alavian SM. Persistence of anti-HBs antibody in children whom vaccinated during infantile period and need to booster needs more discussion. Eur J Pediatr. 2013 Jun;172(6):855.

15.  Assi TM, Brown ST, Kone S, Norman BA, Djibo A, Connor DL, Wateska AR, Rajgopal J, Slayton RB, Lee BY. Removing the regional level from the Niger vaccine supply chain. Vaccine. 2013 Jun 10;31(26):2828 34.

16.  Atchison C, Zvoc M, Balakrishnan R. The evaluation of a standardized call/recall system for childhood immunizations in Wandsworth, England. J Community Health. 2013 Jun;38(3):581-7.

17.  Auffret M, Béné J, Gautier S, Moreau-Crépeaux S, Caron J. Pharmacovigilance monitoring of a cohort of pregnant women vaccinated against influenza A(H1N1) variant virus in the Nord-Pas de Calais region of northern France. Eur J Obstet Gynecol Reprod Biol. 2013 Jun 25. [Epub ahead of print].

18.  Bae EY, Choi UY, Kwon HJ, Jeong DC, Rhim JW, Ma SH, Lee KI, Kang JH. Immunogenicity and safety of an inactivated trivalent split influenza virus vaccine in young children with recurrent wheezing. Clin Vaccine Immunol. 2013 Jun; 20(6):811-7.

19.  Behr MA, Schwartzman K, Pai M. Tuberculosis vaccine trials. Lancet. 2013 Jun  29;381(9885):2252-3.

20.  Behrman A, Lopez AS, Chaves SS, Watson BM, Schmid DS. Varicella immunity in vaccinated healthcare workers. J Clin Virol. 2013 Jun; 57(2):109-14.

21. Benchimol EI, Hawken S, Kwong JC, Wilson K. Safety and utilization of influenza immunization in children with inflammatory bowel disease. Pediatrics. 2013 Jun; 131(6):e1811-20.

22.  Beran TN, Ramirez-Serrano A, Vanderkooi OG, Kuhn S. Reducing children's pain  and distress towards flu vaccinations: A novel and effective application of humanoid robotics. Vaccine. 2013 Jun 7; 31(25):2772-7.

23.  Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens. Vaccine. 2013 Jun 3. [Epub ahead of print].

24.  Bird C. Measles outbreaks threaten those averse to vaccine. CMAJ. 2013 Jun 11;185(9):E393-4.

25.  Biswas G, Sankara DP, Agua-Agum J, Maiga A. Dracunculiasis (guinea worm disease): eradication without a drug or a vaccine. Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120146.

26.  Blackwood JC, Cummings DA, Broutin H, Iamsirithaworn S, Rohani P. Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand. Proc Natl Acad Sci U S A. 2013 Jun 4; 110(23):9595-600.

27.  Blank PR, Schwenkglenks M, Sardos CS, Patris J, Szucs TD. Population access to new vaccines in European countries. Vaccine. 2013 Jun 12; 31(27):2862-7.

28.  Blomberg M, Dehlendorff C, Munk C, Kjaer SK. Strongly decreased risk of genital warts after vaccination against HPV. Nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clin Infect Dis. 2013 Jun 26. [Epub ahead of print].

29.  Boccia TM, Burattini MN, Coutinho FA, Massad E. Will people change their vector-control practices in the presence of an imperfect dengue vaccine? Epidemiol Infect. 2013 Jun 5:1-9. [Epub ahead of print].

30. Bonduelle O, Yahia N, Siberil S, Benhabiles N, Carrat F, Krivine A, Rozenberg F, Dimitrov J, Kaveri SV, Curjol A, Tindel M, Louet M, Desert F, Launay O, Loulergue P, Badre G, Katlama C, Bricaire F, Samri A, Rousset D, van der Werf S,  Jauréguiberry S, Combadiere B. Longitudinal and Integrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination.  J Immunol. 2013 Jun 17. [Epub ahead of print].

31.  Bresse X, Annemans L, Préaud E, Bloch K, Duru G, Gauthier A. Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness  analysis. Expert Rev Pharmacoecon Outcomes Res. 2013 Jun; 13(3):393-406.

32.  Brydak LB, Wozniak-Kosek A, Nitsch-Osuch A. Influenza diagnosis and vaccination in Poland. Respir Physiol Neurobiol. 2013 Jun 1;187(1):88-93.

33.  Bryer J. Black Parents' Beliefs, Attitudes, and HPV Vaccine Intentions. Clin  Nurs Res. 2013 Jun 6. [Epub ahead of print].

34.  Capua T, Katz JA, Bocchini JA Jr. Update on adolescent immunizations: selected review of US recommendations and literature. Curr Opin Pediatr. 2013 Jun;25(3):397-406.

35.  Carcione D, Blyth CC, Mak DB, Effler PV. User satisfaction with the Western Australian Vaccine Safety Surveillance (WAVSS) System. Aust N Z J Public Health.  2013 Jun; 37(3):296.  

36.  Carter NJ. Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero(®)): A Review of its Use in Primary and Booster Vaccination. BioDrugs. 2013 Jun; 27(3):263-74.

37.  Castilla J, Martínez-Baz I, Godoy P, Toledo D, Astray J, García S, Mayoral JM, Martín V, González-Candelas F, Guevara M, Daz-Borrego J, Torner N, Baricot M, Tamames S, Domínguez A; the CIBERESP Working Group for the Survey on Influenza Vaccination in Primary Healthcare Professionals. Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011. Prev Med. 2013 [Epub ahead of print].

38.  Chavant F, Ingrand I, Jonville-Bera AP, Plazanet C, Gras-Champel V, Lagarce L, Zenut M, Disson-Dautriche A, Logerot S, Auffret M, Coubret-Dumas A, Bruel ML,  Boyer M, Bos-Thompson MA, Veyrac G, Carlier P, Beyens MN, Lates S, Damase-Michel  C, Castot A, Kreft-Jaïs C, Pérault-Pochat MC. The PREGVAXGRIP Study: a Cohort Study to Assess Foetal and Neonatal Consequences of In Utero Exposure to Vaccination Against A(H1N1)v2009 Influenza. Drug Saf. 2013 Jun;36(6):455-65.

39.  Chesson HW, Flagg EW, Koutsky L, Hsu K, Unger ER, Shlay JC, Kerndt P, Ghanem  KG, Zenilman JM, Hagensee M, Weinstock H, Datta SD. Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States. Vaccine. 2013 Jun 24; 31(29):3019-24.

40.  Choi UY, Lee SY, Kim KH, Kim DS, Choi KM, Cha SH, Kang JH. Is a Booster Dose Necessary in Children after Immunization with Live Attenuated Japanese Encephalitis Vaccine? J Trop Pediatr. 2013 Jun 13. [Epub ahead of print].

41.  Choi WS, Noh JY, Seo YB, Baek JH, Lee J, Song JY, Park DW, Lee JS, Cheong HJ, Kim WJ. Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory confirmed influenza virus infection in the korean adult population. Clin Vaccine Immunol. 2013 Jun; 20(6):877-81.

42.  Cogman AR, Chakravarty EF. The case for Zostavax vaccination in systemic lupus erythematosus. Vaccine. 2013 Jun 3. [Epub ahead of print].

43.  Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustemapasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, Vázquez M. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccine. Pediatrics. 2013 Jun 17. [Epub ahead of print].

44.  Crawford NW, Graham SM. EV71 vaccine: protection from a previously neglected disease. Lancet. 2013 Jun 8; 381(9882):1968-70.

45.  Dagan R, Patterson S, Juergens C, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA. Comparative immunogenicity and efficacy of 13-valent and  7-valent pneumococcal conjugate vaccine in reducing nasopharyngeal colonization:  a randomized double-blind trial. Clin Infect Dis. 2013 Jun 26. [Epub ahead of print].

46.  Dasari V, Smith C, Khanna R. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases. Expert Rev Vaccines. 2013 Jun;12(6):661-76.

47.  Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P,  Garman P, Gimeno MV, Heijbel H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Sanchez FG, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; the Global H1N1 GBS Consortium. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013 Jun 13. [Epub ahead of print].

48.  Domachowske JB, Pankow-Culot H, Bautista M, Feng Y, Claeys C, Peeters M, Innis BL, Jain V. A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3-17 Years. J Infect Dis. 2013 Jun;207(12):1878-87.

49.  Dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CR, Gilio AE, Martinez MB. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. Vaccine. 2013 Jun 6. [Epub ahead of print].

50.  Doshi P. Influenza vaccines: time for a rethink. JAMA Intern Med. 2013 Jun 10;173(11):1014-6.  

51.  Durham DP, Mbah ML, Medlock J, Luz PM, Meyers LA, Paltiel AD, Galvani AP. Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine. 2013 Jun 20. [Epub ahead of print].

52.  Eguchi S, Takatsuki M, Soyama A, Torashima Y, Tsuji A, Kuroki T. False positivity for the human immunodeficiency virus antibody after influenza Vaccination in a living donor for liver transplantation. Liver Transpl. 2013 Jun; 19(6):666.

53.  Elena Santolaya M, O'Ryan M, Teresa Valenzuela M, Prado V, Vergara RF, Muñoz  A, Toneatto D, Graña G, Wang H, Dull PM. Persistence of antibodies in adolescents 18-24 mo after immunization with one, two or three doses of 4CMenB meningococcal  serogroup B vaccine. Hum Vaccin Immunother. 2013 Jun 28;9(11). [Epub ahead of print].

54.  Eppes C, Wu A, You W, Cameron KA, Garcia P, Grobman W. Barriers to influenza  vaccination among pregnant women. Vaccine. 2013 Jun 12;31(27):2874-8.

55.  Ernsting A, Schwarzer R, Lippke S, Schneider M. 'I do not need a flu shot because I lead a healthy lifestyle': Compensatory health beliefs make vaccination less likely. J Health Psychol. 2013 Jun; 18(6):825-36.

56.  Estívariz CF, Pallansch MA, Anand A, Wassilak SG, Sutter RW, Wenger JD, Orenstein WA. Poliovirus vaccination options for achieving eradication and securing the endgame. Curr Opin Virol. 2013 Jun 8. [Epub ahead of print].

57.  Falchi A, Souty C, Grisoni ML, Mosnier A, Hanslik T, Daviaud I, Varesi L, Kerneis S, Carrat F, Blanchon T. Field seasonal influenza vaccine effectiveness:  Evaluation of the screening method using different sources of data during the 2010/2011 French influenza season. Hum Vaccin Immunother. 2013 Jun 28; 9(11). [Epub ahead of print].

58.  Falzarano D, Feldmann H. Vaccines for viral hemorrhagic fevers-progress and shortcomings. Curr Opin Virol. 2013 Jun 14. [Epub ahead of print].

59.  Ferrari MJ, Grenfell BT, Strebel PM. Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control. Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24; 368(1623):20120141.

60.  Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, Wasserman R, Localio AR. Effectiveness of Decision Support for Families, Clinicians, or Both on HPV Vaccine Receipt. Pediatrics. 2013 Jun;131(6):1114-24.

61.  Findlow J. Meningococcal group B vaccines. Hum Vaccin Immunother. 2013 Jun 1;9(6). [Epub ahead of print].

62.  Fisker AB, Bale C, Jørgensen MJ, Balde I, Hornshøj L, Bibby BM, Aaby P, Benn  CS. High-dose vitamin A supplementation administered with vaccinations after 6 months of age: Sex-differential adverse reactions and morbidity. Vaccine. 2013 Jun 28; 31(31):3191-8.

63.  Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for  studies of the effectiveness of influenza vaccine. Vaccine. 2013 Jun 26; 31(30):3104-9.

64.  Fox CB. Modern Vaccines/Adjuvants Formulation Session 6: Vaccine & Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland. Hum Vaccin Immunother. 2013 Jun 20; 9(9). [Epub ahead of print].

65.  Frey SE, Winokur PL, Salata RA, El-Kamary SS, Turley CB, Walter EB Jr, Hay CM, Newman FK, Hill HR, Zhang Y, Chaplin P, Tary-Lehmann M, Belshe RB. Safety and immunogenicity of IMVAMUNE(®) smallpox vaccine using different strategies for a post event scenario. Vaccine. 2013 Jun 24; 31(29):3025-33.

66.  Gaillat J. Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults. Med Mal Infect. 2013 Jun 12. [Epub ahead of print].

67.  Galagan SR, Paul P, Menezes L, Lamontagne DS. Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. Vaccine. 2013 Jun 26;31(30):3072-8.

68.  Gattoc L, Nair N, Ault K. Human papillomavirus vaccination: current indications and future directions. Obstet Gynecol Clin North Am. 2013 Jun;40(2):177-97.

69.  Gavaldà J, Cabral E, Perez-Romero P, Len O, Aydillo T, Campins M, Quintero J, Peghin M, Nieto J, Charco R, Pahissa A, Cordero E; Spanish Network for the Research in Infectious Diseases (REIPI). Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients. Pediatr Transplant. 2013 Jun; 17(4):403-6.

70. Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM, Daley MF, Belongia EA, Baxter R, Fireman BH, Jackson ML, Omer SB, Nordin JD, Jin R, Weintraub ES, Vijayadeva V, Lee GM. Guillain-Barré Syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011. PLoS One. 2013 Jun 26; 8(6): e67185.

71.  Girard MP, Tam JS, Pervikov Y, Katz JM. Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013. Vaccine. 2013 Jun 26. [Epub ahead of print]. 

72.  González Martínez F, Navarro Gómez ML, Saavedra Lozano J, Santos Sebastián MM, Rodríguez Fernández R, González Snchéz M, Cercenado Mansilla E, Hernández-Sampelayo Matos T. [Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of the 7-valent conjugate vaccine.]. An Pediatr (Barc). 2013 Jun 21. [Epub ahead of print].

73.  Gowda C, Dempsey AF. The rise (and fall?) of parental vaccine hesitancy. Hum Vaccin Immunother. 2013 Jun 6;9(8). [Epub ahead of print].

74.  Grant L, Watt J, Moulton L, Weatherholtz R, Reid R, Santosham M, O'Brien K. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by  vaccination with orally administered rotavirus vaccine. J Pediatr Gastroenterol Nutr. 2013 Jun; 56(6):635-40.

75.  Grgiè-Vitek M. Estimating vaccination coverage against tick-borne encephalitis: Comment on: Košnik IG, Lah AK. A campaign to increase the vaccination rate in a highly endemic tick-borne encephalitis region of Slovenia. Vaccine 2013;31(5):732-4. Vaccine. 2013 Jun 6. [Epub ahead of print].

76.  Guichon JR, Mitchell I, Buffler P, Caplan A. Citizen intervention in a religious ban on in-school HPV vaccine administration in Calgary, Canada. Prev Med. 2013 Jun 13. [Epub ahead of print].

77.  Gupta N. What about vaccinating women with cervical intraepithelial neoplasia against human papillomavirus infection? BMJ. 2013 Jun 11; 346:f3733.

78.  Gupta NK, Upadhyay A, Agarwal A, Goswami G, Kumar J, Sreenivas V. Randomized  controlled trial of topical EMLA and breastfeeding for reducing pain during wDPT vaccination. Eur J Pediatr. 2013 Jun 29. [Epub ahead of print].

79.  Haber P, Patel M, Pan Y, Baggs J, Haber M, Museru O, Yue X, Lewis P, Destefano F, Parashar UD. Intussusception After Rotavirus Vaccines Reported to US VAERS, 2006-2012. Pediatrics. 2013 Jun; 131(6):1042-9. 

80.  Haile ZT, Chertok IR, Teweldeberhan AK. Determinants of utilization of sufficient tetanus toxoid immunization during pregnancy: evidence from the Kenya  Demographic and Health Survey, 2008-2009. J Community Health. 2013 Jun; 38(3):492-9.

81.  Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Shane Pankratz V, Poland GA. Race and Sex-Based Differences in Cytokine Immune Responses to Smallpox Vaccine in Healthy Individuals. Hum Immunol. 2013 Jun 24. [Epub ahead of print].

82.  He Q, Xu J, Chen X, Lu J, Li K, Li Z, Wang M, Yang Q, Dong Z, Liu X, Wu X, Hu W, Zhang D, Lv J, Nie J, Zhu W, Fu C. Effectiveness of seasonal influenza vaccine against clinically diagnosed influenza over two consecutive seasons in children in Guangzhou, China: A matched case-control study. Hum Vaccin Immunother. 2013 Jun 3; 9(8). [Epub ahead of print].

83.  Heier MS, Gautvik KM, Wannag E, Bronder KH, Midtlyng E, Kamaleri Y, Storsaeter J. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 2013 Jun 14. [Epub ahead of print].

84.  Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S, de Vries LD, Smits GP, van Gageldonk PG, Berbers GA, Wulffraat NM. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA. 2013 Jun 19; 309(23):2449-56.

85.  Hemming M, Räsänen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013 Jun; 172(6):739-46.

86.  Hendriks J, Blume S. Measles Vaccination: Before the Measles-Mumps-Rubella Vaccine. Am J Public Health. 2013 Jun 13. [Epub ahead of print].

87.  Hill PL, Nickel LB, Roberts BW. Are You in a Healthy Relationship?: Linking  Conscientiousness to Health via Implementing and Immunizing  Behaviours. J Pers. 2013 Jun 21. [Epub ahead of print].

88.  Hofstetter AM, Rosenthal SL. Health care professional communication about STI vaccines with adolescents and parents. Vaccine. 2013 Jun 20. [Epub ahead of print].

89.  Hogan ME, Probst J, Wong K, Riddell RP, Katz J, Taddio A. A Randomized-controlled Trial of Parent-led Tactile Stimulation to Reduce Pain During Infant Immunization Injections. Clin J Pain. 2013 Jun 14. [Epub ahead of print].

90.  Hoon Han S, Hee Woo J, Weber F, Joo Kim W, Ran Peck K, Il Kim S, Hwa Choi Y, Myung Kim J. Immunogenicity and safety of Intanza (®) /IDflu (®) intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial. Hum Vaccin Immunother. 2013 Jun 18; 9(9). [Epub ahead of print].

91.  Hopkins RJ, Daczkowski NF, Kaptur PE, Muse D, Sheldon E, Laforce C, Sari S,  Rudge TL, Bernton E. Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909  (AV7909) in healthy adult volunteers. Vaccine. 2013 Jun 26; 31(30):3051-8.

92.  Hoshi SL, Kondo M, Okubo I. Economic evaluation of vaccination programme of  13-valent pneumococcal conjugate vaccine to the birth cohort in Japan. Vaccine. 2013 Jun 7;31(25):2762-71.

92.  Huang CL, Nguyen PA, Kuo PL, Iqbal U, Hsu YH, Jian WS. Influenza vaccination and reduction in risk of ischemic h3art disease among chronic obstructive pulmonary elderly. Comput Methods Programs Biomed. 2013 Jun 11. [Epub ahead of print].

94.  Imdad A, Tserenpuntsag B, Blog DS, Halsey NA, Easton DE, Shaw J. Religious Exemptions for Immunization and Risk of Pertussis in New York State, 2000-2011. Pediatrics. 2013 Jun 3. [Epub ahead of print].

95.  Iorizzo M, Marazza G. Measles, mumps, and rubella vaccine: a new option to treat common warts? Int J Dermatol. 2013 Jun 20. [Epub ahead of print].

96.  Ip M, Chau SS, Lai LS, Ma H, Chan PK, Nelson EA. Increased nasopharyngeal carriage of serotypes 6A, 6C, and 6D Streptococcus pneumoniae after introduction  of childhood pneumococcal vaccination in Hong Kong. Diagn Microbiol Infect Dis. 2013 Jun; 76(2):153-7.

97.  Itatani T, Shimizu S, Iwasa M, Ohkusa Y, Hayakawa K. Cost-effectiveness analysis of a pertussis vaccination programme for Japan considering intergenerational infection. Vaccine. 2013 Jun 12; 31(27):2891-7.

98.  Jackson C, Mann A, Mangtani P, Fine P. Effectiveness of Haemophilus influenzae Type b Vaccines Administered According to Various Schedules: Systematic Review and Meta-Analysis of Observational Data. Pediatr Infect Dis J.  2013 Jun 27. [Epub ahead of print].

99.  Jansen KU, Girgenti DQ, Scully IL, Anderson AS. Vaccine review: "Staphyloccocus aureus vaccines: Problems and prospects". Vaccine. 2013 Jun 7;31(25):2723-30.

100. Jin CQ, Dong HX, Sun ZX, Zhou JW, Dou CY, Lu SH, Yang RR. Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV). Hum Vaccin Immunother. 2013 Jun 4;9(8). [Epub ahead of print].

101. Jo DS, Kim JH, Choi EH, Park SE, Kim YJ, Kim YK, Lee J, Eun BW, Lee SY, Lee  H, Kim KH, Kim KH; Korean Pediatric Society, Committee on Infectious Diseases. Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013. Korean J Pediatr. 2013 Jun; 56(6):231-4.

102. Johansen HK, Gøtzsche PC. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis. Cochrane Database Syst Rev. 2013 Jun 17; 6:CD001399.

103. Juárez-Reyes A, Noyola D, Monsiváis-Urenda A, Alvarez-Quiroga C, González-Amaro R. Influenza but not H1N1 influenza immunization is associated with changes in peripheral blood NK cell subset levels. Clin Vaccine Immunol. 2013 Jun 19. [Epub ahead of print].

104. Kaljee LM, Pach A, Thriemer K, Ley B, Jiddawi M, Puri M, Ochiai L, Wierzba T, Clemens J, Ali SM. Desirability for a typhoid fever vaccine among rural residents, Pemba Island, Tanzania. Vaccine. 2013 Jun 24;31(29):2994-9.

105. Karron RA, Thumar B, Schappell E, Buchholz UJ, Collins PL. Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines. J Infect Dis. 2013 Jun 1; 207(11):1773-9.

106. Kelso JM. Allergic reactions after immunization. Ann Allergy Asthma Immunol. 2013 Jun; 110(6):397-401.

107. Kempe A, Saville A, Dickinson LM, Eisert S, Reynolds J, Herrero D, Beaty B,  Albright K, Dibert E, Koehler V, Lockhart S, Calonge N. Population-based versus practice-based recall for childhood immunizations: a randomized controlled comparative effectiveness trial. Am J Public Health. 2013 Jun; 103(6):1116-23.

108. Kim YK, Eun BW, Kim NH, Kang EK, Lee BS, Kim DH, Lim JS. Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6-35 months. Scand J Infect Dis. 2013 Jun; 45(6):460-8.

109. Kiraly N, Dharmage SC, Allen KJ. Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole-Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines May Have Been Confounded by Age. Clin Infect Dis. 2013 Jun 14. [Epub ahead of print].

110. Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013 Jun;131(6):e1716-22.

111. Kobashigawa T, Nakajima A, Taniguchi A, Inoue E, Tanaka E, Momohara S, Yamanaka H. Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort. Scand J Rheumatol. 2013 Jun 3. [Epub ahead of print].

112. Korppi M, Karppa H, Vuento R. Universal pneumococcal vaccination of <2-year-olds decreased pneumococcal bacteremia and antibiotic resistance in <5-year-olds. Acta Paediatr. 2013 Jun; 102(6):e239-40.

113. Kramer L. Experts question timing of vaccination against shingles. CMAJ. 2013 Jun 10. [Epub ahead of print].

114. Kulpeng W, Leelahavarong P, Rattanavipapong W, Sornsrivichai V, Baggett HC,  Meeyai A, Punpanich W, Teerawattananon Y. Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? Vaccine. 2013 Jun 10;31(26):2839-47.

115. Kuschner RA, Russell KL, Abuja M, Bauer KM, Faix DJ, Hait H, Henrick J, Jacobs M, Liss A, Lynch JA, Liu Q, Lyons AG, Malik M, Moon JE, Stubbs J, Sun W, Tang D, Towle AC, Walsh DS, Wilkerson D; Adenovirus Vaccine Efficacy Trial Consortium. A phase 3, randomized, double-blind, placebo-controlled study of the  safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits. Vaccine. 2013 Jun 19;31(28):2963-71.

116. Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, Stukel TA, Crowcroft NS, McGeer AJ, Zinman L, Deeks SL. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis. 2013 Jun 27. [Epub ahead of print].

117. Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter AL, Olsha R, Turner R, Rosella LC, Crowcroft NS. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis. 2013 Jun 20. [Epub ahead of print].

118. Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Meritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F. Control of humoral immunity and auto immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine. Vaccine. 2013 Jun 10. [Epub ahead of print].

119. Laurence S, Chappuis M, Rodier P, Labaume C, Corty JF. [Measles vaccination  campaign among vulnerable populations during the peak of the 2011 epidemic in Marseilles]. Rev Epidemiol Sante Publique. 2013 Jun; 61(3):199-203.

120. Ledgerwood JE. AS03-adjuvanted influenza vaccine in elderly people. Lancet Infect Dis. 2013 Jun; 13(6):466-7.

121. Lee PI, Chen PY, Huang YC, Lee CY, Lu CY, Chang MH, Lin YZ, Chiu NC, Ni YH,  Chen CM, Chang LY, Tang RB, Huang LM, Huang YF, Hwang KP, Hwang B, Lin TY. Recommendations for Rotavirus Vaccine. Pediatr Neonatol. 2013 Jun 5. [Epub ahead of print].

122. Lee SS, Leung EH, Wong NS. Concerns for low coverage of influenza vaccination in middle-aged adults. Hum Vaccin Immunother. 2013 Jun 21; 9(9). [Epub ahead of print].

123. Lefebvre JS, Haynes L. Vaccine strategies to enhance immune responses in the aged. Curr Opin Immunol. 2013 Jun 10. [Epub ahead of print].

124. Lehmann BA, Ruiter RA, Kok G. A qualitative study of the coverage of influenza vaccination on Dutch news sites and social media websites. BMC Public Health. 2013 Jun 5;13:547.

125. Leung DT, Uddin T, Xu P, Aktar A, Johnson RA, Rahman MA, Alam MM, Bufano MK, Eckhoff G, Wu-Freeman Y, Yu Y, Sultana T, Khanam F, Saha A, Chowdhury F, Khan AI, Charles RC, Larocque RC, Harris JB, Calderwood SB, Kovác P, Qadri F, Ryan ET. Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh. Clin Vaccine Immunol. 2013 Jun; 20(6):780-8.

126. Li RC, Li YP, Mo ZJ, Luo D, Huang T, Kong JL, Wang LH, Song NS, Liu A, Zhang H, Liao X, Karkada N, Han HH. Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies. Hum Vaccin Immunother. 2013 Jun 4; 9(8). [Epub ahead of print].

127.  Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, Yao X, Gao F, Wu X, Xu M, Wang JZ. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother. 2013 Jun 6; 9(8). [Epub ahead of print].

128. Lin SY, Wu ET, Lin CH, Shyu MK, Lee CN. The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in taiwan. PLoS One. 2013 Jun 6; 8(6):e62983.

129.  Lindow JC, Durbin AP, Whitehead SS, Pierce KK, Carmolli MP, Kirkpatrick BD.  Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles. Vaccine. 2013 Jun 2. [Epub ahead of print].

130.  Lindsey B, Kampmann B, Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis. 2013 Jun; 26(3):248-53.

131. Love B, Himelboim I, Holton A, Stewart K. Twitter as a source of vaccination information: Content drivers and what they are saying. Am J Infect Control. 2013 Jun; 41(6):568-70.

132. Lungarde K, Blaizeau F, Auger-Aubin I, Floret D, Gilberg S, Jestin C, Hanslik T, Le Goaster C, Lévy-Bruhl D, Blanchon T, Rossignol L. How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groups. BMC Fam Pract. 2013 Jun 19;14:85.

133. Luyten J, Desmet P, Dorgali V, Hens N, Beutels P. Kicking against the pricks: vaccine sceptics have a different social orientation. Eur J Public Health. 2013 Jun 28. [Epub ahead of print].

134. Macias VC, Cunha D. Psoriasis triggered by tetanus-diphtheria vaccination. Cutan Ocul Toxicol. 2013 Jun;32(2):164-5.

135. Maclennan CA. Vaccines for low-income countries. Semin Immunol. 2013 Jun 8.  [Epub ahead of print].

136. Maiden MC. The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis? Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24; 368(1623):20120147.

137. Manning ML, Davis J. Journal Club: Twitter as a source of vaccination information: Content drivers and what they're saying. Am J Infect Control. 2013 Jun; 41(6):571-2.

138. Marshall HS, Collins J, Sullivan T, Tooher R, O'Keefe M, Skinner SR, Watson  M, Burgess T, Ashmeade H, Braunack-Mayer A. Parental and societal support for adolescent immunization through school based immunization programs. Vaccine. 2013 Jun 26;31(30):3059-64.

139. McElhaney JE, Beran J, Devaster JM, Esen M, Launay O, Leroux-Roels G, Ruiz-Palacios GM, van Essen GA, Caplanusi A, Claeys C, Durand C, Duval X, El Idrissi M, Falsey AR, Feldman G, Frey SE, Galtier F, Hwang SJ, Innis BL, Kovac M, Kremsner P, McNeil S, Nowakowski A, Richardus JH, Trofa A, Oostvogels L; Influence65 study group. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis. 2013 Jun; 13(6):485-96.

140. McGregor AC, Waddington CS, Pollard AJ. Prospects for prevention of Salmonella infection in children through vaccination. Curr Opin Infect Dis. 2013 Jun; 26(3):254-62.

141. Mitchell P, Turner N, Jennings L, Dong H. Previous vaccination modifies both the clinical disease and immunological features in children with measles. J Prim  Health Care. 2013 Jun 1; 5(2):93-8.

142. Mitkus RJ, Hess MA, Schwartz SL. Pharmacokinetic modeling as an approach to  assessing the safety of residual formaldehyde in infant vaccines. Vaccine. 2013 Jun 7; 31(25):2738-43.

143. Müller RB, Maier R, Hoschler K, Zambon M, Ludewig B, Herrmann M, Schulze-Koops H, von Kempis J. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination. Clin Exp Rheumatol. 2013 Jun 14. [Epub ahead of print].

144. Mészner Z, Anca I, André F, Chlibek R, Ci×man M, Grzesiowski P, Mangarov A,  Pokorn M, Prymula R, Richter D, Salman N, Simurka P, Tamm E, Tešoviæ G, Urbancikova I, Usonis V, Zavadska D; on Behalf of the Central European Vaccine Awareness Group (CEVAG). Rotavirus Vaccination in Central Europe. J Pediatr Gastroenterol Nutr. 2013 Jun; 56(6):586-596.

145. Müller-Ladner C, Müller-Ladner U. Vaccination and inflammatory arthritis: overview of current vaccines and recommended uses in rheumatology. Curr Rheumatol Rep. 2013 Jun; 15(6):330.

146. Naito T. An initiative offering free pneumococcal vaccination to victims of  the Great East Japan earthquake. Thorax. 2013 Jun 5. [Epub ahead of print].

147. Nakamura R, Togashi T. Population-Based Incidence of Invasive Haemophilus influenzae and Pneumococcal Diseases before the Introduction of Vaccines in Japan. Pediatr Infect Dis J. 2013 Jun 25. [Epub ahead of print].

148. Naleway AL, Gold R, Kurosky S, Riedlinger K, Henninger ML, Nordin JD, Kharbanda EO, Irving S, Cheetham TC, McCarthy NL. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine. 2013 Jun 12; 31(27):2898-903.

149. Ndeffo Mbah ML, Medlock J, Meyers LA, Galvani AP, Townsend JP. Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine. 2013 Jun 26; 31(30):3079-89.

150. Nelson EA, Lam HS, Choi KC, Ho WC, Fung LW, Cheng FW, Sung RY, Royals M, Chan PK. A pilot randomized study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18-26 years. Vaccine. 2013 Jun  12. [Epub ahead of print].

151. Nitsch-Osuch A, Korzeniewski K, Kuchar E, Zielonka T, Zyciñska K, Wardyn K.  Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults. Respir Physiol Neurobiol. 2013 Jun 1; 187(1):99-103.

152. Nowalk MP, Nolan BA, Nutini J, Ahmed F, Albert SM, Susick M, Zimmerman RK. Success of the 4 Pillars Toolkit for Influenza and Pneumococcal Vaccination in Adults. J Healthc Qual. 2013 Jun 18. [Epub ahead of print].

153. O'Connor AC, Kennedy ED, Loomis RJ, Haque SN, Layton CM, Williams WW, Amoozegar JB, Braun FM, Honeycutt AA, Weinbaum C. Prospective cost-benefit analysis of a two-dimensional barcode for vaccine production, clinical documentation, and public health reporting and tracking. Vaccine. 2013 Jun 28; 31(31):3179-86.

154. Okeibunor JC, Akanmori BD, Balcha GM, Mihigo R, Vaz RM, Nshimirimana D. Enhancing access to immunization services and exploiting the benefits of recent innovations in the African region. Vaccine. 2013 Jun 22. [Epub ahead of print].

155. Orr N, Elliott MN, Burkhart Q, Haviland A, Weinick RM. Racial/Ethnic Differences in Medicare Experiences and Immunization: The Role of Disease Burden. Med Care. 2013 Jun 25. [Epub ahead of print].

156. Ouédraogo N, Kagoné M, Sié A, Becher H, Müller O. Immunization coverage in young children: A study nested into a health and demographic surveillance system  in Burkina Faso. J Trop Pediatr. 2013 Jun; 59(3):187-94.

157. Ozawa S, Stack ML. Public trust and vaccine acceptance-international perspectives. Hum Vaccin Immunother. 2013 Jun 3;9(8). [Epub ahead of print].

158. Pabst LJ, Chaves SS, Weinbaum C. Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years. Vaccine. 2013 Jun 28;31(31):3116-20.

159. Park BM, Ahn JS, Lee JB, Won YH, Yun SJ. Chronic Active Epstein-Barr Virus Infection-Associated Hydroa Vacciniforme-Like Eruption and Behçet's-Like Orogenital Ulcers. Dermatology. 2013 Jun 1. [Epub ahead of print].

160. Patel MM, Patzi M, Pastor D, Nina A, Roca Y, Alvarez L, Iniguez V, Rivera R, Tam KI, Quaye O, Bowen M, Parashar U, De Oliveira LH. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ. 2013 Jun 19; 346:f3726.

161. Pavia-Ruz N, Angel Rodriguez Weber M, Lau YL, Nelson EA, Phirangkul AK, Huang LM, Silas P, Qaqundah P, Blatter M, Jeanfreau R, Lei P, Jain V, El Idrissi  M, Feng Y, Innis B, Peeters M, Devaster JM. A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age. Hum Vaccin Immunother. 2013 Jun 19; 9(9). [Epub ahead of print].

162. Pendleton A, Galic M, Clarke C, Ng SP, Ledesma E, Ramakrishnan G, Liu Y. Impact of rotavirus vaccination in Australian children below 5 years of age: A database study. Hum Vaccin Immunother. 2013 Jun 3;9(8). [Epub ahead of print].

163. Pereira BF, Martins MA, Barbosa TL, Silva CS, Gomes LM. [Reasons why pregnant women did not vaccinate against Influenza A H1N1]. Cien Saude Colet. 2013 Jun; 18(6):1745-52.

164. Person CJ, Nadeau JA, Schaffzin JK, Pollock L, Wallace BJ, McNutt LA, Blog D. Influenza immunization coverage of residents and employees of long-term care facilities in New York State, 2000-2010. Am J Infect Control. 2013 Jun 20. [Epub ahead of print].

165. Poland GA, Kennedy RB, McKinney BA, Ovsyannikova IG, Lambert ND, Jacobson RM, Oberg AL. Vaccinomics, adversomics, and the immune response network theory: Individualized vaccinology in the 21st century. Semin Immunol. 2013 Jun 4. [Epub ahead of print].

166. Polewicz M, Gracia A, Garlapati S, van Kessel J, Strom S, Halperin SA, Hancock RE, Potter AA, Babiuk LA, Gerdts V. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence  of maternal antibodies. Vaccine. 2013 Jun 28; 31(31):3148-55.

167. Puig-Barberà J, Natividad-Sancho A, Calabuig-Pérez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martínez-Úbeda S, Pérez-Vilar S, Díez-Domingo J. MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system. Vaccine. 2013 Jun 1. [Epub ahead of print].

168. Pérez GM, Parra A, Casimir L, Mastroianni A, Reijtman V, Lopardo H, Bologna  R. Invasive infections caused by Streptococcus pneumoniae in a terciary care pediatric hospital before the introduction of the conjugate vaccine: Clinical characteristics and serotypes involved. Arch Argent Pediatr. 2013 Jun; 111(3):202-205.

169. Pérez-Rubio A, Bouza JM. [An experience of the use of cell culture-derived influenza vaccines in an influenza vaccination campaign.]. Gac Sanit. 2013 Jun 27. [Epub ahead of  print].

170. Pías-Peleteiro L, Cortés-Bordoy J, Martinón-Torres F. Dr. Google: What about the human papillomavirus vaccine? Hum Vaccin Immunother. 2013 Jun 6; 9(8). [Epub ahead of print].

171. Quinn SC, Parmer J, Freimuth VS, Hilyard KM, Musa D, Kim KH. Exploring Communication, Trust in Government, and Vaccination Intention Later in the 2009 H1N1 Pandemic: Results of a National Survey. Biosecur Bioterror. 2013 Jun;11(2):96-106.

172. Ramsay M, Brown K. The public health implications of secondary measles vaccine failure. J Prim Health Care. 2013 Jun 1; 5(2):92.

173. Rashid H, Abdul Muttalif AR, Mohamed Dahlan ZB, Djauzi S, Iqbal Z, Karim HM, Naeem SM, Tantawichien T, Zotomayor R, Patil S, Schmitt HJ. The potential for pneumococcal vaccination in Hajj pilgrims: Expert opinion. Travel Med Infect Dis. 2013 Jun 27. [Epub ahead of print].

174. Razafindratsimandresy R, Joffret ML, Rabemanantsoa S, Andriamamonjy S, Heraud JM, Delpeyroux F. Reemergence of Recombinant Vaccine-derived Polioviruses  in Healthy Children, Madagascar. Emerg Infect Dis. 2013 Jun; 19(6):1008-10.

175. Rebmann T, Wang J, Swick Z, Reddick D, Minden-Birkenmaier C. Health care versus non-health care businesses' experiences during the 2009 H1N1 pandemic: Financial impact, vaccination policies, and control measures implemented. Am J Infect Control. 2013 Jun; 41(6):e49-54.

176. Richards JL, Wagenaar BH, Van Otterloo J, Gondalia R, Atwell JE, Kleinbaum DG, Salmon DA, Omer SB. Nonmedical exemptions to immunization requirements in California: A 16-year longitudinal analysis of trends and associated community factors. Vaccine. 2013 Jun 24; 31(29):3009-13.

177. Richman AR, Swanson RS, Branham AR, Partridge BN. Measuring North Carolina Pharmacists' Support for Expanded Authority to Administer Human Papillomavirus Vaccines. J Pharm Pract. 2013 Jun 6. [Epub ahead of print].

178. Rittle C. Promoting Universal Vaccination Among Workers. Workplace Health Saf. 2013 Jun 24:314-322. [Epub ahead of print].

179. Riva MA, Sormani M. Anti-HBs evaluation and booster dose in vaccinated healthcare students. Vaccine. 2013 Jun 26. [Epub ahead of print].

180. Robison SG. Sick-Visit Immunizations and Delayed Well-Baby Visits. Pediatrics. 2013 Jun 3. [Epub ahead of print].

181. Ropeik D. How society should respond to the risk of vaccine rejection. Hum Vaccin Immunother. 2013 Jun 6; 9(8). [Epub ahead of print].

182. Rosado MM, Gesualdo F, Marcellini V, Di Sabatino A, Corazza GR, Smacchia MP, Nobili B, Baronci C, Russo L, Rossi F, De Vito R, Nicolosi L, Inserra A, Locatelli F, Tozzi AE, Carsetti R. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies. Eur J Immunol. 2013 Jun 28. [Epub ahead of print].

183. Rossmann Beel E, Rench MA, Montesinos DP, Mayes B, Healy CM. Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother. 2013 Jun 19;9(9). [Epub ahead of print].

184. Rousseau-Gouesnou N, Develay S, Moyo L, Staumont-Straczek H, Jacquot M, Vic  P. [Parental information about pertussis vaccination in a maternity ward]. J Gynecol Obstet Biol Reprod (Paris). 2013 Jun; 42(4):405-6.

185. Rowland R, O'Hara GA, Hamill M, Poulton ID, Donaldson H, Dinsmore L, James T, Barnes E, Klenerman P, Gilbert SC, Hill AV, Shine B, McShane H. Determining the validity of hospital laboratory reference intervals for healthy young adults  participating in early clinical trials of candidate vaccines. Hum Vaccin Immunother. 2013 Jun 3; 9(8). [Epub ahead of print].

186. Saint-Victor DS, Omer SB. Vaccine refusal and the endgame: walking the last mile first. Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24; 368(1623):20120148.

187. Saitoh A, Nagata S, Saitoh A, Tsukahara Y, Vaida F, Sonobe T, Kamiya H, Naruse T, Murashima S. Perinatal immunization education improves immunization rates and knowledge: a randomized controlled trial. Prev Med. 2013 Jun; 56(6):398-405.

188. Sangster MY, Baer J, Santiago FW, Fitzgerald T, Ilyushina NA, Sundararajan A, Henn AD, Krammer F, Yang H, Luke CJ, Zand MS, Wright PF, Treanor JJ, Topham DJ, Subbarao K. B Cell Response and Hemagglutinin Stalk-Reactive Antibody Production in Different Age Cohorts following 2009 H1N1 Influenza Virus Vaccination. Clin Vaccine Immunol. 2013 Jun; 20(6):867-76.

189. Sauvageau C, Dubé E, Bradet R, Mondor M, Lavoie F, Moisan J. Immunization services offered in Québec (Canada) pharmacies. Hum Vaccin Immunother. 2013 Jun 19; 9(9). [Epub ahead of print].

190. Scheiblhofer S, Thalhamer J, Weiss R. Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines. Expert Opin Drug Deliv. 2013 Jun; 10(6):761-73.

191. Sharma SK, Roumanes D, Almudevar A, Mosmann TR, Pichichero ME. CD4(+) T-cell responses among adults and young children in response to Streptococcus pneumonia and Haemophilus influenzae vaccine candidate protein antigens. Vaccine. 2013 Jun 26; 31(30):3090-7.

192. Shelby A, Ernst K. Story and science: How providers and parents can utilize  storytelling to combat anti-vaccine misinformation. Hum Vaccin Immunother. 2013 Jun 28; 9(8). [Epub ahead of print].

193. Shen S, Campitelli MA, Calzavara A, Guttmann A, Kwong JC. Seasonal influenza vaccine effectiveness in pre- and full-term children aged 6-23 months over multiple seasons. Vaccine. 2013 Jun 24;31(29):2974-8.

194. Sigle JP, Thierbach J, Infanti L, Muriset M, Hunziker G, Chassot K, Niederhauser C, Gowland P, Holbro A, Sunic K, Buser A, Fontana S. Anti-leucocyte  antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI p revention. Vox Sang. 2013 Jun 16. [Epub ahead of print].

195. Simancas-Racines D, Guerra CV, Hidalgo R. Vaccines for the common cold. Cochrane Database Syst Rev. 2013 Jun 12; 6:CD002190.

196. Sommerfleck P, González Macchi ME, Pellegrini S, Bernáldez P, Reijtman V, Hernández C, Lopardo H. Acute otitis media in infants younger than three months not vaccinated against Streptococcus pneumoniae. Int J Pediatr Otorhinolaryngol.  2013 Jun; 77(6):976-80.

197. Song JY, Moseley MA, Burton RL, Nahm MH. Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother. 2013 Jun;19(3):412-25.

198. Soonawala D, Verdijk P, Wijmenga-Monsuur AJ, Boog CJ, Koedam P, Visser LG, Rots NY. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults. Vaccine. 2013 Jun 13. [Epub ahead of print].

199. Specker B, Wey B, Fuller J, Sandoval MN, Durkin M, Dole N, Walter EB Jr. 2009 H1N1 and Seasonal Influenza Immunization Among Pregnant Women: A Comparison  of Different Sources of Immunization Information. Matern Child Health J. 2013 Jun 23. [Epub ahead of print].

200. Spila-Alegiani S, Da Cas R, Giambi C, Raschetti R, Salmaso S. [Human papillomavirus vaccine register]. Recenti Prog Med. 2013 Jun; 104(6):262-6.

201. Starr M. Paediatric travel medicine: vaccines and medications. Br J Clin Pharmacol. 2013 Jun; 75(6):1422-32.

202. Stockwell MS, Fiks AG. Utilizing health information technology to improve vaccine communication and coverage. Hum Vaccin Immunother. 2013 Jun 4; 9(8). [Epub ahead of print].

203. Sundaram ME, McClure DL, Vanwormer JJ, Friedrich TC, Meece JK, Belongia EAInfluenza Vaccination is Not Associated with Detection of Non-Influenza Respiratory Viruses in Seasonal Studies of Influenza Vaccine Effectiveness. Clin  Infect Dis. 2013 Jun 6. [Epub ahead of print].

204. Sánchez-Arreola PB, López-Uriarte S, Marichal-Gallardo PA, González-Vázquez  JC, Pérez-Chavarría R, Soto-Vázquez P, López-Pacheco F, Ramírez-Medrano A, Rocha-Pizaña MR, Alvarez MM. A baseline process for the production, recovery, and purification of bacterial influenza vaccine candidates. Biotechnol Prog. 2013 Jun 8. [Epub ahead of print].

205. Tacke CE, Smits GP, van der Klis FR, Kuipers IM, Zaaijer HL, Kuijpers TW. Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease. J Allergy Clin Immunol. 2013 Jun;131(6):1701-3.

206. Talbot HK, Zhu Y, Chen Q, Williams JV, Thompson MG, Griffin MR. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza  hospitalizations in adults, 2011-2012 influenza season. Clin Infect Dis. 2013 Jun; 56(12):1774-7.

207. Tameris M, Hatherill M, Mahomed H, McShane H. Tuberculosis vaccine trials -  Authors' reply. Lancet. 2013 Jun 29; 381(9885):2254.

208. Tiblad E, Westgren M, Pasupathy D, Karlsson A, Wikman AT. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies. Acta Obstet Gynecol Scand. 2013 Jun 11. [Epub ahead of print].

209. Tocheva AS, Jefferies JM, Christodoulides M, Faust SN, Clarke SC. Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: A 3-year cross-sectional population based analysis. Vaccine. 2013 Jun 28; 31(31):3187-90.

210. Tomljenovic L, Shoenfeld Y. Association between vaccination and Guillain-Barré syndrome. Lancet Infect Dis. 2013 Jun 27. [Epub ahead of print].

211. Tonnis WF, Lexmond AJ, Frijlink HW, de Boer AH, Hinrichs WL. Devices and formulations for pulmonary vaccination. Expert Opin Drug Deliv. 2013 Jun 21. [Epub ahead of print].

212. Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013 Jun 25; 11(1):153. [Epub ahead of print].

213. Trück J, O'Connor D, Darton TC, John TM, Snape MD, Pollard AJ. Genetic material should be routinely collected in clinical vaccine trials - High consent  rates can be achieved across all age groups. Vaccine. 2013 Jun 7; 31(25):2744-8.

214. Tuells J. [Reasons for an injury compensation programme for adverse vaccine-related events in Spain]. Med Clin (Barc). 2013 Jun 18; 140(12):554-7.

215. Upadhyay P. Tuberculosis vaccine trials. Lancet. 2013 Jun 29; 381(9885):2253-4.

216. Uphoff H, Wirtz A, Jahn K, Hauri AM. [Pandemic 2009/10: Reflections on the Utility of the Vaccination Actions in Hesse.]. Gesundheitswesen. 2013 Jun 11. [Epub ahead of print].

217. Verbeek NE, van der Maas NA, Jansen FE, van Kempen MJ, Lindhout D, Brilstra  EH. Prevalence of SCN1A-Related Dravet Syndrome among Children Reported with Seizures following Vaccination: A Population-Based Ten-Year Cohort Study. PLoS One. 2013 Jun 6;8(6):e65758.

218. Viaris de Lesegno B, Beucher G, Lamendour N, D'Alché-Gautier MJ, Dreyfus M,  Benoist G. [Continuous medical evaluation of the prevention of fetomaternal rhesus-D allo-immunization]. J Gynecol Obstet Biol Reprod (Paris). 2013 Jun;42(4):359-65.

219. Vratskikh O, Stiasny K, Zlatkovic J, Tsouchnikas G, Jarmer J, Karrer U, Roggendorf M, Roggendorf H, Allwinn R, Heinz FX. Dissection of Antibody Specificities Induced by Yellow Fever Vaccination. PLoS Pathog. 2013 Jun; 9(6):e1003458.

220. Wallace D, Canouet V, Garbes P, Wartel TA. Challenges in the clinical development of a dengue vaccine. Curr Opin Virol. 2013 Jun 6. [Epub ahead of print].

221. Wang FH, Xie Z, Lv M, Deng Y, Zhang TH. [Analysis of the difference in free  influenza vaccination rates between old people in urban and rural areas in Beijing]. Beijing Da Xue Xue Bao. 2013 Jun 18; 45(3):432-6. 

222. Welch TR. Generalists' role in vaccine safety reporting. J Pediatr. 2013 Jun; 162(6):1088.

223. Wiley KE, Massey PD, Cooper SC, Wood N, Quinn HE, Leask J. Pregnant women's  intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: A cross sectional survey. Vaccine. 2013 Jun 15. [Epub ahead of print]. 

224. Williams SE, Edwards KM, Baxter RP, Larussa PS, Halsey NA, Dekker CL, Vellozzi C, Marchant CD, Donofrio PD, Reimschisel TE, Berger M, Gidudu JF, Klein  NP. Comprehensive assessment of serious adverse events following immunization by  health care providers. J Pediatr. 2013 Jun; 162(6):1276-1281.e1.

225. Woertman W, Jan van der Wilt G. Estimating the Effectiveness of HPV Vaccination in the Open Population: A Bayesian Approach. Value Health. 2013 Jun; 16(4):604-9.

226. Wong CA, Taylor JA, Wright JA, Opel DJ, Katzenellenbogen RA. Missed Opportunities for Adolescent Vaccination, 2006-2011. J Adolesc Health. 2013 Jun 25. [Epub ahead of print].

227. Xie O, Pollard AJ, Mueller JE, Norheim G. Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine. Vaccine. 2013 Jun 12; 31(27):2852-61.

228. Yang CF, Wang CK, Malkin E, Schickli JH, Shambaugh C, Zuo F, Galinski MS, Dubovsky F; Study Group, Tang RS. Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine. Vaccine. 2013 Jun 10;31(26):2822-7.

229. Ye Y, Wang CS, Ma YT, Lu MX, Zhang XX, Zhang YY, Guo WS. [Surveillance of adverse events following immunization in Henan Province, China between 2010-2011]. Zhongguo Dang Dai Er Ke Za Zhi. 2013 Jun; 15(6):466-71.

230. Yi J, Anderson EJ. Rotavirus vaccination: short-term indirect herd protection, long-term uncertainty. Expert Rev Vaccines. 2013 Jun; 12(6):585-7.

231. Yin L, Calvo-Calle JM, Cruz J, Newman FK, Frey SE, Ennis FA, Stern LJ. CD4+  T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus-Vaccinated Humans. J Immunol. 2013 Jun 15; 190(12):6023-33.

232. Zaccaro DJ, Wagener DK, Whisnant CC, Staats HF. Evaluation of vaccine-induced antibody responses: Impact of new technologies. Vaccine. 2013 Jun 7; 31(25):2756-61.

233. Zheteyeva Y, Moro PL, Yue X, Broder K. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol. 2013 Jun; 208(6):478.e1-6.

234. Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, Hu YM, Wu X, Liu P, Zhu LY, Gao F, Jin H, Chen YJ, Dong YY, Liang YC, Shi NM, Ge HM, Liu L, Chen SG, Ai X, Zhang ZY, Ji YG, Luo FJ, Chen XQ, Zhang Y, Zhu LW, Liang ZL, Shen XL. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013 Jun 8; 381(9882):2024-32.

[Top]